Advertisement

Topics

Lightyear Capital Company Profile

22:54 EDT 19th September 2018 | BioPortfolio

Lightyear Capital is a leading private equity firm making primarily control investments in North America based, middle-market financial services companies. Based in New York, Lightyear, through its affiliated funds, has managed approximately $3 billion of committed capital with investments across the financial services spectrum, including asset management, banking, brokerage, financial technology, insurance, and specialty finance. Lightyear brings unique strengths and discipline to its investment process, as well as operating, transaction, and strategic management experience, along with significant contacts and resources beyond capital. The senior team of professionals averages over 25 years of financial services-related experience and includes Chris Casciato, David Cynn, Michael Doppelt, Stewart Gross, Thierry Ho, Donald Marron, Richard Sterne, and Mark Vassallo.


News Articles [535 Associated News Articles listed on BioPortfolio]

Lightyear Capital Closes Sale of Alegeus to Vista Equity Partners

Lightyear Capital LLC (“Lightyear”), a New York-based private equity firm focused on financial services investing, today announced the completion of the sale by its affiliated...

Therapy Brands Closes Investment from Lightyear Capital and Oak HC/FT to Accelerate Growth

Proven Management Team of Comprehensive Healthcare Information Technology Platform for Mental & Behavioral Health Providers to Continue to Drive Growth Therapy Bran...

Vista Equity Partners to Acquire Leading Consumer Directed Healthcare Firm Alegeus

Investment will accelerate the next phase of growth in Alegeus’ mission to transform consumer healthcare funding Alegeus, the market leader in consumer directed healt...

Brii Biosciences launches with $260mm

Brii Biosciences has launched with committed funding of $260mm from Arch Venture Partners, 6 Dimensions Capital, Boyu Capital, Yunfeng Capital, Sequoia Capital, and Blue Pool Capital.

SkyBridge And HNA Capital Announce Termination Of SkyBridge Transaction

NEW YORK, April 30, 2018/PRNewswire/ --  SkyBridge Capital("SkyBridge"), a leading global alternative investment firm, and HNA Capital (U.S.) Holding ("HNA Capital") today Read more...

Viela Bio launches with $250mm Series A

Viela Bio, a new company developing autoimmune and inflammatory disease therapeutics, raised $250mm in its Series A round. Boyu Capital, 6 Dimensions Capital, and Hillhouse Capital led, and were joine...

TCR2 closes $125mm Series B round

TCR2 Therapeutics Inc. (immuno-oncology) raised $125mm through its Series B round. Curative Ventures and 6 Dimensions Capital co-led and were joined by additional new investors Redmile Group, ArrowMar...

Brii Bio Starts Operations with $260 Million to Bring Drugs to China

Brii Bio, a China-US startup, raised $260 million in initial capital to bring innovative drugs to China. So far, Brii has options on China rights to four biotech infectious disease assets from Vir of ...

PubMed Articles [115 Associated PubMed Articles listed on BioPortfolio]

What is the association between social capital and diabetes mellitus? A systematic review.

Social capital has been included as an element that could influence the self-perception of health, mortality and mental diseases. We systematically reviewed papers that studied the influence of social...

"Who'll do all these if I'm not around?": Bonding social capital and health and well-being of inpatients.

Although social capital influences health-related decisions and behavioural patterns in many developing countries, minimal attention has been paid to the nuances of its effect on healthcare. This pape...

Association Between Community Social Capital and Hospital Readmission Rates.

Hospital readmissions remain frequent, and are partly attributable to patients' social needs. The authors sought to examine whether local community levels of social capital are associated with hospita...

Is community social capital associated with subjective symptoms of dementia among older people? A cross-sectional study in Japan.

Many studies have reported the preventive effects of community social capital on health outcomes, such as mortality and incidence of diseases. However, evidence on the association between community so...

Social capital interventions in public health: A systematic review.

Despite two decades of research on social capital and health, intervention studies remain scarce. We performed a systematic review on social capital interventions in public health and searched the Pub...

Clinical Trials [47 Associated Clinical Trials listed on BioPortfolio]

Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV

The study is a randomized controlled trial to evaluate the social capital intervention versus a general health promotion intervention (Health for Life; H4L) among groups of Young black men...

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

The Montreal Neighbourhood Networks and Healthy Aging Panel

Social networks, social capital, i.e., network-accessed resources, and neighbourhood environments have been shown associated with a range of health behaviours and conditions, including obe...

"Gait and Balance in Patients With SCFE"

Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in an altered gait. It is thought that the protraction of the pelvis at the affected side, seen in ...

Social Inequalities in Emergency Call and Emergency Response Patterns

Background: Inequality in access to healthcare is a challenge internationally. Despite that medical emergency calls can be considered as access point to pre-hospital emergency care and ...

Companies [1070 Associated Companies listed on BioPortfolio]

Lightyear Capital

Lightyear Capital is a leading private equity firm making primarily control investments in North America based, middle-market financial services companies. Based in New York, Ligh...

Lightyear Capital LLC

Founded in 2000, Lightyear Capital is a financial services-focused private equity firm based in New York. Through its affiliated private equity funds, Lightyear makes primarily co...

Irving Place Capital

Irving Place Capital invests private equity capital in buyouts, recapitalizations, and growth capital opportunities alongside superior management teams. Irving Place Capital focus...

MCG Capital Corporation

MCG Capital Corporation is a solutions-focused commercial finance company providing capital and advisory services to middle-market companies throughout the United States. Our inve...

Praesidian Capital

Praesidian Capital partners with small and mid-sized businesses, providing private debt capital. With a focus on its core competency in mezzanine financing, Praesidian Capital invests in established, ...

More Information about "Lightyear Capital" on BioPortfolio

We have published hundreds of Lightyear Capital news stories on BioPortfolio along with dozens of Lightyear Capital Clinical Trials and PubMed Articles about Lightyear Capital for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lightyear Capital Companies in our database. You can also find out about relevant Lightyear Capital Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record